These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 11008533

  • 1. [The obesity epidemics--do diet pills have a place in the treatment?].
    Tonstad S, Birkeland KI.
    Tidsskr Nor Laegeforen; 2000 Jun 30; 120(17):1997-2001. PubMed ID: 11008533
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacological management of obesity.
    Hanif MW, Kumar S.
    Expert Opin Pharmacother; 2002 Dec 30; 3(12):1711-8. PubMed ID: 12472368
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Antiobesity drugs--new limitations].
    Nau JY.
    Rev Med Suisse; 2007 Nov 28; 3(135):2753. PubMed ID: 18214233
    [No Abstract] [Full Text] [Related]

  • 7. [Pharmacotherapy in the treatment of obesity].
    Hamann A.
    MMW Fortschr Med; 2006 Mar 02; 148(9):36-8. PubMed ID: 16566392
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacotherapy of obesity].
    Hamann A.
    Internist (Berl); 2008 Jan 02; 49(1):106-13. PubMed ID: 18060334
    [Abstract] [Full Text] [Related]

  • 9. [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine].
    Richter WO.
    MMW Fortschr Med; 1999 Dec 09; 141(49-50):32-6. PubMed ID: 10726144
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term pharmacotherapy for obesity.
    Klein S.
    Obes Res; 2004 Dec 09; 12 Suppl():163S-6S. PubMed ID: 15687412
    [Abstract] [Full Text] [Related]

  • 12. [Weight loss via drug therapy].
    Wirth A.
    Internist (Berl); 2003 Mar 09; 44(3):359-62, 363-6. PubMed ID: 12731423
    [Abstract] [Full Text] [Related]

  • 13. Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.
    Whigham LD, Dhurandhar NV, Rahko PS, Atkinson RL.
    Int J Obes (Lond); 2007 May 09; 31(5):850-7. PubMed ID: 17146452
    [Abstract] [Full Text] [Related]

  • 14. Weight management and current options in pharmacotherapy: orlistat and sibutramine.
    Leung WY, Thomas GN, Chan JC, Tomlinson B.
    Clin Ther; 2003 Jan 09; 25(1):58-80. PubMed ID: 12637112
    [Abstract] [Full Text] [Related]

  • 15. Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.
    Davis R, Faulds D.
    Drugs; 1996 Nov 09; 52(5):696-724. PubMed ID: 9118819
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modern medical management of obesity: the role of pharmaceutical intervention.
    Aronne LJ.
    J Am Diet Assoc; 1998 Oct 09; 98(10 Suppl 2):S23-6. PubMed ID: 9787732
    [Abstract] [Full Text] [Related]

  • 18. Pharmacotherapy of obesity.
    Finer N.
    Best Pract Res Clin Endocrinol Metab; 2002 Dec 09; 16(4):717-42. PubMed ID: 12468417
    [Abstract] [Full Text] [Related]

  • 19. What are the risks and the benefits of current and emerging weight-loss medications?
    Robinson JR, Niswender KD.
    Curr Diab Rep; 2009 Oct 09; 9(5):368-75. PubMed ID: 19793507
    [Abstract] [Full Text] [Related]

  • 20. Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial.
    Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Arnold ME, Steinberg CM.
    Obes Res; 2000 Sep 09; 8(6):431-7. PubMed ID: 11011909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.